Monday, April 27, 2009
Swine Flu Stocks
By now, anyone who has a TV, radio, gets the newspaper, or has Internet access has heard of the swine flu outbreak. Many investors think that the flu scare has had a significant effect on various stocks, some positively and some negatively. Here are a few that may benefit on the long side due to this outbreak.
GlaxoSmithKline plc (GSK) makes the Relenza inhaled flu drug. The stock has a PE of 12 and a yield of 5.6%.
Gilead Sciences (GILD) developed Tamiflu. The stock has a PE of 21.
Roche (RHHBF.PK) makes Tamiflu.
Novartis AG (NVS) is working on a flu virus vaccine. The stock has a PE of 10 and a yield of 4.7%.
Johnson & Johnson (JNJ) markets Purell hand sanitizer and surgical masks. The stock has a PE of 11 and a yield of 3.8%.
If you are interested in a downloadable Excel database of High Yield Big Pharma stocks, go to WallStreetNewsNetwork.com.
Author does not own any of the above.